Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

Kimia Farma Tbk PT stock price, quote, forecast and news

KAEF.JK
ID1000070303

Price

605.00 IDR
Today +/-
+0 IDR
Today %
+0 %
P

Kimia Farma Tbk PT Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Kimia Farma Tbk PT, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Kimia Farma Tbk PT from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Kimia Farma Tbk PT’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Kimia Farma Tbk PT. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Kimia Farma Tbk PT’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Kimia Farma Tbk PT’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Kimia Farma Tbk PT’s growth potential.

Kimia Farma Tbk PT Revenue, EBIT and net profit per share

DateKimia Farma Tbk PT RevenueKimia Farma Tbk PT EBITKimia Farma Tbk PT Net Income
20239.97 T IDR-1.56 T IDR-1.49 T IDR
20229.23 T IDR489.77 B IDR-190.47 B IDR
202112.86 T IDR968.21 B IDR302.27 B IDR
202010.01 T IDR652.05 B IDR17.64 B IDR
20199.4 T IDR492.58 B IDR-12.72 B IDR
20188.46 T IDR922.25 B IDR491.57 B IDR
20176.13 T IDR505.91 B IDR326.79 B IDR
20165.81 T IDR443.26 B IDR267.41 B IDR
20154.86 T IDR387.92 B IDR261.43 B IDR
20144.52 T IDR341.64 B IDR255.93 B IDR
20134.35 T IDR272.27 B IDR214.55 B IDR
20123.74 T IDR255.67 B IDR200.57 B IDR
20113.48 T IDR222 B IDR171.77 B IDR
20103.18 T IDR146.2 B IDR138.72 B IDR
20092.85 T IDR111.93 B IDR62.51 B IDR
20082.7 T IDR107.04 B IDR55.39 B IDR
20072.37 T IDR77.5 B IDR52.19 B IDR
20062.19 T IDR60.63 B IDR43.99 B IDR
20051.82 T IDR84.72 B IDR52.83 B IDR
20041.93 T IDR124.71 B IDR77.76 B IDR

Kimia Farma Tbk PT Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (T IDR)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (T IDR)EBIT (B IDR)EBIT MARGIN (%)NET INCOME (B IDR)NET INCOME GROWTH (%)DIV. (IDR)DIV. GROWTH (%)SHARES (B)DOCUMENTS
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
1.521.421.541.821.931.822.192.372.72.853.183.483.744.354.524.865.816.138.469.410.0112.869.239.97
--6.228.1518.056.03-5.6920.558.0314.335.5211.559.347.3016.403.987.5119.575.4438.0511.136.4428.50-28.197.93
36.5036.0928.9329.8833.5731.7727.1527.3926.7027.6228.4129.8231.3429.7230.6531.6232.0735.9339.4937.1336.1833.8040.4129.05
0.550.510.450.540.650.580.590.650.720.790.91.041.171.291.391.541.862.23.343.493.624.353.732.89
249.92173.8860.8788.66124.7184.7260.6377.5107.04111.93146.2222255.67272.27341.64387.92443.26505.91922.25492.58652.05968.21489.77-1,561.56
16.4712.223.964.886.484.662.773.283.963.924.596.386.846.267.567.987.638.2610.905.246.527.535.30-15.67
169.82132.2635.4142.9377.7652.8343.9952.1955.3962.51138.72171.77200.57214.55255.93261.43267.41326.79491.57-12.7217.64302.27-190.47-1,485.56
--22.12-73.2321.2481.12-32.06-16.7318.646.1412.84121.9223.8216.776.9719.292.152.2922.2050.42-102.59-238.621,613.77-163.01679.93
------------------------
------------------------
55.285.555.555.555.555.555.555.555.555.555.555.555.555.555.555.555.555.555.555.555.555.565.56
------------------------
Details

Keystats

ⓘ

Revenue and Growth

The Kimia Farma Tbk PT Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Kimia Farma Tbk PT is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M IDR)RECEIVABLES (M IDR)OTHER REC. (M IDR)INVENTORIES (M IDR)OTHER CURRENT LIAB. (M IDR)CURRENT ASSETS (M IDR)TANGIBLE ASSETS (M IDR)LONG-T. INVEST. (M IDR)LONG-T. REC. (M IDR)INTANGIBLE ASSETS (M IDR)GOODWILL (M IDR)OTHER NON-CURRENT ASSETS (M IDR)NON-CURRENT ASSETS (M IDR)TOTAL ASSETS (M IDR)LIABILITIESCOMMON STOCK (M IDR)ADDITIONAL PAID-IN CAPITAL (M IDR)RETAINED EARNINGS (M IDR)OTHER EQUITY (M IDR)UNREAL. GAINS/LOSSES (M IDR)EQUITY (M IDR)LIABILITIES (M IDR)PROVISIONS (M IDR)OTHER SHORT-TERM LIAB. (M IDR)SHORT-TERM DEBTS (M IDR)LONG-TERM DEBT PORTION (M IDR)SHORT-TERM REC. (M IDR)LONG-T. LIAB. (M IDR)DEFERRED TAXES (M IDR)OTHER LIAB. (M IDR)LONG-T. LIABILITIES (M IDR)DEBT (M IDR)TOTAL CAPITAL (M IDR)
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Kimia Farma Tbk PT provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Kimia Farma Tbk PT's financial health and stability.

Assets

Kimia Farma Tbk PT's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Kimia Farma Tbk PT must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Kimia Farma Tbk PT after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Kimia Farma Tbk PT's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M IDR)DEPRECIATION (M IDR)DEFERRED TAXES (M IDR)CHANGES IN WORKING CAPITAL (B IDR)NON-CASH ITEM (M IDR)PAID INTEREST (M IDR)PAID TAXES (B IDR)NET CASH FLOW FROM OPERATING ACTIVITIES (T IDR)CAPITAL EXPENDITURES (M IDR)CASH FLOW FROM INVESTING ACTIVITIES (M IDR)CASH FLOW FROM OTHER INVESTING ACTIVITIES (B IDR)INTEREST INCOME AND EXPENSES (M IDR)NET DEBT CHANGE (T IDR)NET CHANGE IN EQUITY (B IDR)CASH FLOW FROM FINANCING ACTIVITIES (T IDR)CASH FLOW FROM OTHER FINANCING ACTIVITIES (T IDR)TOTAL DIVIDENDS PAID (M IDR)NET CHANGE IN CASH FLOW (T IDR)FREE CASH FLOW (M IDR)SHARE-BASED COMPENSATION (M IDR)
20002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022
00000000000000000000000
00000000000000000000000
00000000000000000000000
16.1845.935.938.9817.420.7633.96110.5441.6927.1466.3332.1413.62-1,175.77-1,347.59-1,495.52-1,728.82-2,011.39-2,628.01-3,521.51-3,547.09-3,746-3,471.98
00000000000000000000000
-26,050-13,186-21,733-11,616-3,566-7,542-10,141-6,415-16,874-25,486-14,337-12,059-6,808-9,640-21,869-36,142-62,735-85,951-227,220-490,407-596,377-606,813-508,373
-45.41-68.13-59.68-14.71-29.47-44.47-39.12-31.68-43.16-28.52-3.78-19.2313.05-47.410.6233.8245.17328.4123.87254.6551.08147.649.61
0.140.06-0.070.31-0.080.030.140.06-0.030.120.140.080.240.250.290.180.20.010.17-1.851.02-0.220.05
-44,684-45,886-69,383-46,270-35,650-34,331-23,982-31,553-30,658-34,483-30,456-34,832-60,602-89,030-102,577-149,384-371,721-753,308-1.25 M-778,866-548,574-659,252-596,612
-62,906855-66,539-49,040-41,609-29,152-23,016-28,202-26,571-73,862-13,325-54,389-73,293-172,809-331,588-228,503-478,919-810,237-1.56 M-2.12 M-539,954-648,454-119,416
-18.2246.742.84-2.77-5.965.180.973.354.09-39.3817.13-19.56-12.69-83.78-229.01-79.12-107.2-56.93-310.62-1,345.818.6210.8477.2
00000000000000000000000
-0.040.06-0.01-0.09-0.02-0-0.02-00.07-0.09-0.02-0.03-0.010.030.28-0.010.51.192.53.4-0.560.380.08
098.98000000000000000000000
-0.090.12-0.07-0.1-0.04-0.03-0.04-0.010.06-0.1-0.02-0.09-0.05-00.22-0.060.471.152.323.28-0.590.361.46
00000000000-0.0200000.020.010.01-0.04-0.03-0.011.39
-44,528-33,964-59,159-10,622-17,171-23,190-15,612-13,110-17,808-13,8480-46,277-34,353-30,770-53,855-46,925-49,769-53,485-182,810-83,1980-702-9,023
0.180.27-0.20.5-0.220.040.23-0-0.020.090.190.010.331.561.821.562.132.123.941.24.53.485.39
94,16012,341-140,446268,357-110,695-3,735116,26123,960-62,95985,887108,66446,721174,711164,754183,732.1226,582.71-173,670.55-748,066.75-1.08 M-2.63 M470,400.84-883,177.44-544,868.75
00000000000000000000000

Kimia Farma Tbk PT stock margins

The Kimia Farma Tbk PT margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Kimia Farma Tbk PT. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Kimia Farma Tbk PT.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Kimia Farma Tbk PT's sales revenue. A higher gross margin percentage indicates that the Kimia Farma Tbk PT retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Kimia Farma Tbk PT's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Kimia Farma Tbk PT's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Kimia Farma Tbk PT's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Kimia Farma Tbk PT. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Kimia Farma Tbk PT's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Kimia Farma Tbk PT Margin History

Kimia Farma Tbk PT Gross marginKimia Farma Tbk PT Profit marginKimia Farma Tbk PT EBIT marginKimia Farma Tbk PT Profit margin
202329.05 %-15.67 %-14.91 %
202240.41 %5.3 %-2.06 %
202133.8 %7.53 %2.35 %
202036.18 %6.52 %0.18 %
201937.13 %5.24 %-0.14 %
201839.49 %10.9 %5.81 %
201735.93 %8.26 %5.33 %
201632.07 %7.63 %4.6 %
201531.62 %7.98 %5.38 %
201430.65 %7.56 %5.66 %
201329.72 %6.26 %4.93 %
201231.34 %6.84 %5.37 %
201129.82 %6.38 %4.93 %
201028.41 %4.59 %4.36 %
200927.62 %3.92 %2.19 %
200826.7 %3.96 %2.05 %
200727.39 %3.28 %2.21 %
200627.15 %2.77 %2.01 %
200531.77 %4.66 %2.91 %
200433.57 %6.48 %4.04 %

Kimia Farma Tbk PT Stock Sales Revenue, EBIT, Earnings per Share

The Kimia Farma Tbk PT earnings per share therefore indicates how much revenue Kimia Farma Tbk PT has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Kimia Farma Tbk PT earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Kimia Farma Tbk PT's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Kimia Farma Tbk PT’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Kimia Farma Tbk PT's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Kimia Farma Tbk PT Revenue, EBIT and net profit per share

DateKimia Farma Tbk PT Sales per ShareKimia Farma Tbk PT EBIT per shareKimia Farma Tbk PT Earnings per Share
20231,791.76 IDR-280.78 IDR-267.11 IDR
20221,660.2 IDR88.07 IDR-34.25 IDR
20212,315.02 IDR174.33 IDR54.42 IDR
20201,801.62 IDR117.4 IDR3.18 IDR
20191,692.57 IDR88.69 IDR-2.29 IDR
20181,523.09 IDR166.05 IDR88.51 IDR
20171,103.26 IDR91.09 IDR58.84 IDR
20161,046.36 IDR79.81 IDR48.15 IDR
2015875.11 IDR69.84 IDR47.07 IDR
2014814.01 IDR61.51 IDR46.08 IDR
2013782.87 IDR49.02 IDR38.63 IDR
2012672.55 IDR46.03 IDR36.11 IDR
2011626.79 IDR39.97 IDR30.93 IDR
2010573.25 IDR26.32 IDR24.98 IDR
2009513.87 IDR20.15 IDR11.25 IDR
2008486.99 IDR19.27 IDR9.97 IDR
2007425.93 IDR13.95 IDR9.4 IDR
2006394.26 IDR10.92 IDR7.92 IDR
2005327.05 IDR15.25 IDR9.51 IDR
2004346.78 IDR22.45 IDR14 IDR

Kimia Farma Tbk PT business model

Kimia Farma Tbk PT is one of the most popular companies on Eulerpool.com.

Kimia Farma Tbk PT historical P/E ratio, EBIT, and P/S ratio.

Kimia Farma Tbk PT shares outstanding

The number of shares was Kimia Farma Tbk PT in 2023 — This indicates how many shares 5.562 B is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Kimia Farma Tbk PT earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Kimia Farma Tbk PT's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Kimia Farma Tbk PT’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Kimia Farma Tbk PT's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Kimia Farma Tbk PT dividend history and estimates

In 2023, Kimia Farma Tbk PT paid a dividend amounting to 0 IDR. Dividend means that Kimia Farma Tbk PT distributes a portion of its profits to its owners.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

ⓘ

Dividend Overview

The dividend per year chart for Kimia Farma Tbk PT provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Kimia Farma Tbk PT’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating Kimia Farma Tbk PT's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

Kimia Farma Tbk PT Dividend History

DateKimia Farma Tbk PT Dividend
202216.33 IDR
20211.27 IDR
201914.98 IDR
201817.66 IDR
20179.63 IDR
20168.96 IDR
20158.45 IDR
20149.66 IDR
20135.54 IDR
20126.19 IDR
20118.37 IDR
20092.49 IDR
20082.82 IDR
20072.37 IDR
20062.85 IDR
20054.18 IDR
20043.09 IDR

Kimia Farma Tbk PT dividend payout ratio

In 2023, Kimia Farma Tbk PT had a payout ratio of 11.72%. The payout ratio indicates the percentage of the company's profits that Kimia Farma Tbk PT distributes as dividends.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

ⓘ

What is Yearly Payout Ratio?

The yearly payout ratio for Kimia Farma Tbk PT represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for Kimia Farma Tbk PT could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate Kimia Farma Tbk PT's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

Kimia Farma Tbk PT Payout Ratio History

DateKimia Farma Tbk PT Payout ratio
202311.72 %
2022-47.67 %
20212.33 %
202012.88 %
2019-653.87 %
201819.95 %
201716.37 %
201618.61 %
201517.95 %
201420.96 %
201314.34 %
201217.13 %
201127.07 %
201012.88 %
200922.13 %
200828.27 %
200725.21 %
200636.02 %
200543.91 %
200422.1 %
Unfortunately, there are currently no price targets and forecasts available for Kimia Farma Tbk PT.

Kimia Farma Tbk PT list of shareholders

%
Name
Stocks
Change
Date
89.82 % PT Bio Farma (Persero)4,999,999,99909/30/2023
4.44 % PT Asabri (Persero)247,237,80009/30/2023
0.76 % Bajened (Abdurahman Said)42,074,70025,00012/31/2022
0.10 % PT Aurora Asset Management5,721,400012/31/2022
0.09 % Fourton Rahastoyhtiö Oy4,909,8004,909,80012/31/2022
0.07 % PT Kimia Farma (Persero) Tbk ESOP4,130,700-239,80012/31/2022
0.07 % PT Emco Asset Management3,885,000012/31/2022
0.04 % Lesmana (Aan)2,240,000012/31/2022
0.04 % Suryasin2,134,500012/31/2022
0.03 % Saputra (Adicipta)1,861,900012/31/2022
1
2

Most common questions regarding Kimia Farma Tbk PT

What is the P/E ratio of Kimia Farma Tbk PT 2024?

The P/E ratio cannot be calculated for Kimia Farma Tbk PT at the moment.

What is the P/S ratio of Kimia Farma Tbk PT 2024?

The P/S cannot be calculated for Kimia Farma Tbk PT currently.

What is the AlleAktien quality score of Kimia Farma Tbk PT?

The AlleAktien quality score for Kimia Farma Tbk PT is 3/10.

What is the revenue of Kimia Farma Tbk PT 2024?

The revenue cannot currently be calculated for Kimia Farma Tbk PT.

How high is the profit of Kimia Farma Tbk PT 2024?

The profit cannot currently be calculated for Kimia Farma Tbk PT.

What is the business model of Kimia Farma Tbk PT

No history available for Kimia Farma Tbk PT.

What is the Kimia Farma Tbk PT dividend?

Kimia Farma Tbk PT pays a dividend of 16.33 IDR distributed over payouts per year.

How often does Kimia Farma Tbk PT pay dividends?

The dividend cannot currently be calculated for Kimia Farma Tbk PT or the company does not pay out a dividend.

What is the Kimia Farma Tbk PT ISIN?

The ISIN of Kimia Farma Tbk PT is ID1000070303.

What is the Kimia Farma Tbk PT ticker?

The ticker of Kimia Farma Tbk PT is KAEF.JK.

How much dividend does Kimia Farma Tbk PT pay?

Over the past 12 months, Kimia Farma Tbk PT paid a dividend of 16.33 IDR . This corresponds to a dividend yield of about 2.7 %. For the coming 12 months, Kimia Farma Tbk PT is expected to pay a dividend of 16.33 IDR.

What is the dividend yield of Kimia Farma Tbk PT?

The current dividend yield of Kimia Farma Tbk PT is 2.7 %.

When does Kimia Farma Tbk PT pay dividends?

Kimia Farma Tbk PT pays a quarterly dividend. This is distributed in the months of May, June, June, June.

How secure is the dividend of Kimia Farma Tbk PT?

Kimia Farma Tbk PT paid dividends every year for the past 0 years.

What is the dividend of Kimia Farma Tbk PT?

For the upcoming 12 months, dividends amounting to 16.33 IDR are expected. This corresponds to a dividend yield of 2.79 %.

In which sector is Kimia Farma Tbk PT located?

Kimia Farma Tbk PT is assigned to the 'Health' sector.

Wann musste ich die Aktien von Kimia Farma Tbk PT kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Kimia Farma Tbk PT from 6/10/2022 amounting to 16.327 IDR, you needed to have the stock in your portfolio before the ex-date on 5/23/2022.

When did Kimia Farma Tbk PT pay the last dividend?

The last dividend was paid out on 6/10/2022.

What was the dividend of Kimia Farma Tbk PT in the year 2023?

In the year 2023, Kimia Farma Tbk PT distributed 1.27 IDR as dividends.

In which currency does Kimia Farma Tbk PT pay out the dividend?

The dividends of Kimia Farma Tbk PT are distributed in IDR.

All fundamentals about Kimia Farma Tbk PT

Our stock analysis for Kimia Farma Tbk PT Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Kimia Farma Tbk PT Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.